Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.

MLA

Bissett, Cameron, et al. “Systemic Prime Mucosal Boost Significantly Increases Protective Efficacy of Bivalent RSV Influenza Viral Vectored Vaccine.” NPJ Vaccines, vol. 9, no. 1, June 2024, p. 118. EBSCOhost, https://doi.org/10.1038/s41541-024-00912-1.

APA

Bissett, C., Belij-Rammerstorfer, S., Ulaszewska, M., Smith, H., Kailath, R., Morris, S., Powers, C., Sebastian, S., Sharpe, H. R., Allen, E. R., Wang, Z., Cunliffe, R. F., Sallah, H. J., Spencer, A. J., Gilbert, S., Tregoning, J. S., & Lambe, T. (2024). Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine. NPJ Vaccines, 9(1), 118. https://doi.org/10.1038/s41541-024-00912-1

Chicago

Bissett, Cameron, Sandra Belij-Rammerstorfer, Marta Ulaszewska, Holly Smith, Reshma Kailath, Susan Morris, Claire Powers, et al. 2024. “Systemic Prime Mucosal Boost Significantly Increases Protective Efficacy of Bivalent RSV Influenza Viral Vectored Vaccine.” NPJ Vaccines 9 (1): 118. doi:10.1038/s41541-024-00912-1.